1-8 of 8
Anu Gupta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract B22: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)

Pascal Hammel, Rosanna Berardi, Eric Van Cutsem, Jaime Feliu, Richard Greil, Harpreet Wasan, Jean-Philippe Metges, Peter Nygren, Pia Österlund, Marcus Noel, Thomas Seufferlein, Geert-Jan Creemers, Anu Gupta, Sophie Salesse, Nigel Biswas-Baldwin, Hedy Dion, Hagop Youssoufian, Iman El-Hariry, Manuel Hidalgo
Journal: Cancer Research
Cancer Res (2019) 79 (24_Supplement): B22.
https://doi.org/10.1158/1538-7445.PANCA19-B22
Published: 13 December 2019
View article titled, Abstract B22: Trybeca-1: A randomized, phase 3 study of eryaspase in combination with chemotherapy versus chemotherapy alone as second-line treatment in patients with pancreatic adenocarcinoma (NCT03665441)
Journal Articles

Abstract 3925: Inhibition of oncogenic and drug-resistant PDGFRA and KIT alterations by DCC-2618

Bryan D. Smith, Michael D. Kaufman, Anu Gupta, Cynthia B. Leary, Wei-ping Lu, Stacie L. Bulfer, Gada Al-Ani, Jarnail Singh, Subha Vogeti, Michael C. Heinrich, Daniel L. Flynn
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 3925.
https://doi.org/10.1158/1538-7445.AM2018-3925
Published: 01 July 2018
View article titled, Abstract 3925: Inhibition of oncogenic and drug-resistant PDGFRA and KIT alterations by DCC-2618
Journal Articles

Abstract LB-039: Translational research in a phase I proof-of-concept study supports that DCC-2618 is a pan-KIT inhibitor

Filip Janku, Albi Razak, Michael Gordon, David Brooks, Daniel Flynn, Anu Gupta, Michael Kaufman, Cynthia Leary, Bryan Smith, Deb Westwood, Neeta Somaiah, Elena Helman, Eric Gerstenberger, Oliver Rosen, Suzanne George
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): LB-039.
https://doi.org/10.1158/1538-7445.AM2017-LB-039
Published: 01 July 2017
View article titled, Abstract LB-039: Translational research in a phase I proof-of-concept study supports that DCC-2618 is a pan-KIT inhibitor
Journal Articles

Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance

Nathalie Javidi-Sharifi, Elie Traer, Jacqueline Martinez, Anu Gupta, Takehiro Taguchi, Jennifer Dunlap, Michael C. Heinrich, Christopher L. Corless, Brian P. Rubin, Brian J. Druker, Jeffrey W. Tyner
Journal: Cancer Research
Cancer Res (2015) 75 (5): 880–891.
https://doi.org/10.1158/0008-5472.CAN-14-0573
Published: 01 March 2015
View article titled, Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance
Open the PDF for Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance in another window
Includes: Supplementary data
Journal Articles

Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma

Anu Gupta, Bryan R.G. Williams, Samir M. Hanash, Jawhar Rawwas
Journal: Cancer Research
Cancer Res (2006) 66 (16): 8100–8108.
https://doi.org/10.1158/0008-5472.CAN-05-4519
Published: 15 August 2006
View article titled, Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma
Open the PDF for Cellular Retinoic Acid–Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma in another window
Journal Articles

CRABP-II is a MycN regulated gene that enhances MycN mRNA stability in neuroblastoma

Anu Gupta, Jawhar Rawwas
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 690.
Published: 01 May 2005
View article titled, CRABP-II is a MycN regulated gene that enhances MycN mRNA stability in neuroblastoma
Journal Articles

Stimulation of Estrogen Receptor Signaling by γ Synuclein

Yangfu Jiang, Yiliang Ellie Liu, AiPing Lu, Anu Gupta, Itzhak D. Goldberg, Jingwen Liu, Y. Eric Shi
Journal: Cancer Research
Cancer Res (2003) 63 (14): 3899–3903.
Published: 21 July 2003
View article titled, Stimulation of Estrogen Receptor Signaling by γ Synuclein
Open the PDF for Stimulation of Estrogen Receptor Signaling by γ Synuclein in another window
Journal Articles

Hypomethylation of the Synuclein γ Gene CpG Island Promotes Its Aberrant Expression in Breast Carcinoma and Ovarian Carcinoma

Anu Gupta, Andrew K. Godwin, Lisa Vanderveer, AiPing Lu, Jingwen Liu
Journal: Cancer Research
Cancer Res (2003) 63 (3): 664–673.
Published: 01 February 2003
View article titled, Hypomethylation of the <em>Synuclein</em> γ Gene CpG Island Promotes Its Aberrant Expression in Breast Carcinoma and Ovarian Carcinoma
Open the PDF for Hypomethylation of the <em>Synuclein</em> γ Gene CpG Island Promotes Its Aberrant Expression in Breast Carcinoma and Ovarian Carcinoma in another window